Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 20;24(3):2045.
doi: 10.3390/ijms24032045.

Sympathetic System in Wound Healing: Multistage Control in Normal and Diabetic Skin

Affiliations
Review

Sympathetic System in Wound Healing: Multistage Control in Normal and Diabetic Skin

Evgenii Ivanov et al. Int J Mol Sci. .

Abstract

In this review, we discuss sympathetic regulation in normal and diabetic wound healing. Experimental denervation studies have confirmed that sympathetic nerve endings in skin have an important and complex role in wound healing. Vasoconstrictor neurons secrete norepinephrine (NE) and neuropeptide Y (NPY). Both mediators decrease blood flow and interact with inflammatory cells and keratinocytes. NE acts in an ambiguous way depending on receptor type. Beta2-adrenoceptors could be activated near sympathetic endings; they suppress inflammation and re-epithelialization. Alpha1- and alpha2-adrenoceptors induce inflammation and activate keratinocytes. Sudomotor neurons secrete acetylcholine (ACh) and vasoactive intestinal peptide (VIP). Both induce vasodilatation, angiogenesis, inflammation, keratinocytes proliferation and migration. In healthy skin, all effects are important for successful healing. In treatment of diabetic ulcers, mediator balance could be shifted in different ways. Beta2-adrenoceptors blockade and nicotinic ACh receptors activation are the most promising directions in treatment of diabetic ulcers with neuropathy, but they require further research.

Keywords: NGF; NPY; VIP; acetylcholine; angiogenesis; diabetes mellitus; keratinocytes; norepinephrine; sympathetic system; wound healing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Normal autonomic skin innervation.

Similar articles

Cited by

References

    1. Hicks C.W., Selvin E. Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes. Curr. Diabetes Rep. 2019;19:86. doi: 10.1007/s11892-019-1212-8. - DOI - PMC - PubMed
    1. Rekha P.-D., Rao S.S., Sahana T.G., Prabhu A. Diabetic wound management. Br. J. Community Nurs. 2018;23:S16–S22. doi: 10.12968/bjcn.2018.23.Sup9.S16. - DOI - PubMed
    1. Boulton A.J., Armstrong D.G., Kirsner R.S., Attinger C.E., Lavery L.A., Lipsky B.A., Mills J.L., Sr., Steinberg J.S. Diagnosis and management of diabetic foot complications. Diabetes. 2018;2018:1–20. doi: 10.2337/db20182-1. - DOI - PubMed
    1. Akkus G., Sert M. Diabetic foot ulcers: A devastating complication of diabetes mellitus continues non-stop in spite of new medical treatment modalities. World J. Diabetes. 2022;13:1106–1121. doi: 10.4239/wjd.v13.i12.1106. - DOI - PMC - PubMed
    1. Ghotaslou R., Memar M.Y., Alizadeh N. Classification, microbiology and treatment of diabetic foot infections. J. Wound Care. 2018;27:434–441. doi: 10.12968/jowc.2018.27.7.434. - DOI - PubMed

MeSH terms